Halloween Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

David BurrowsMedicis Pharmaceutical CorpMRXTOP PICKSep 13, 2006

Sector that has been out of favour and under owned for some time. Have had a tough 3/4 years and have been going through a restructuring. Starting to see some benefits. Kind of stock portfolio managers like to get into in a slowdown.
$31.29

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Uses Restolane in place of Botox. Demographically very attractive.